Great Point Partners Completes Investment in Ephicacy Consulting Group to Fund Accelerated Growth
Summary
Today Great Point Partners (GPP), a Greenwich-based private investment firm focused on the health care industry, announced a growth investment and partnership with Ephicacy Consulting Group, Inc., (Ephicacy), a leading biometrics Contract Research Organization (CRO) with operations in the United States, Canada, and India. Sophisticated data analysis is critical to clinical trial and regulatory success and pharma companies rely on specialized CROs like Ephicacy for outsourced biostatistics support, said Rohan Saikia, Managing Director at Great Point Partners. Ephicacy has been growing rapidly, and we are excited to partner with Ganesh and the rest of the team to accelerate growth.Great Points expertise and investment success in the pharmaceutical services space was clearly evident when they first approached us about a partnership, said Ganesh Gopal, CEO of Ephicacy. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.About Ephicacy Consulting Group, Inc. Headquartered in Iselin, NJ, with employees and operations across North America and India, Ephicacy is a rapidly growing biometrics CRO, providing outsourced statistical programming, data management, and real-world evidence (RWE) analytics services to pharmaceutical and biotechnology companies, primarily under a Functional Service Provider ("FSP") model. Since its founding in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool of over 350 resources to help global pharmaceutical and biotechnology companies reduce their time to market in a cost-effective manner.